Douglas Melton, PhD, co-director of the Harvard Stem Cell Institute, was awarded the prize for his work to treat diabetes with insulin-producing pancreatic cells created from stem cells.
The Ogawa-Yamanaka Stem Cell Prize celebrates scientists whose original translational research has advanced cellular reprogramming technology for regenerative medicine.
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Juan Carlos Izpisua Belmonte, recipient of the 2022 Ogawa-Yamanaka Stem Cell Prize, is turning back the clock on old and sick cells, with many potential benefitsAwards Ogawa Stem Cell Prize Profile Stem Cells/iPSCs
Gladstone investigator is awarded the Legion of HonorAwards Krogan Lab
Katie Pollard is recognized for discovering fast-evolving regions of the human genome and for creating open-source software used by scientists worldwideAwards News Release Data Science and Biotechnology Pollard Lab Big Data